Zobrazeno 1 - 10
of 368
pro vyhledávání: '"Maurizio, Martini"'
Autor:
Alessia Formato, Maria Salbini, Elisa Orecchini, Manuela Pellegrini, Mariachiara Buccarelli, Lucia Ricci Vitiani, Stefano Giannetti, Roberto Pallini, Quintino Giorgio D'Alessandris, Liverana Lauretti, Maurizio Martini, Valentina De Falco, Andrea Levi, Maria Laura Falchetti, Maria Patrizia Mongiardi
Publikováno v:
Cancer Medicine, Vol 13, Iss 19, Pp n/a-n/a (2024)
ABSTRACT Objective Axitinib is a tyrosine kinase inhibitor characterized by a strong affinity for Vascular Endothelial Growth Factor Receptors (VEGFRs). It was approved in 2012 by Food and Drug Administration and European Medicines Agency as a second
Externí odkaz:
https://doaj.org/article/7cc7cde955aa431da8a4db85e35cb3d3
Autor:
Walter Giordano, Gabriele Ricciardi, Marco Casciaro, Vincenzo Fiorentino, Cristina Pizzimenti, Anna Viola, Maurizio Martini, Giovanni Tuccari, Antonio Ieni
Publikováno v:
Gastrointestinal Disorders, Vol 6, Iss 2, Pp 446-460 (2024)
Inflammatory bowel disease (IBD) represents a heterogenous and complex group of idiopathic chronic inflammatory conditions affecting the gastrointestinal tract and other extraintestinal systems with rising global incidences. The interplay of genetic
Externí odkaz:
https://doaj.org/article/9b4a9d22ea444808a826944b47a5a7b3
Autor:
Vincenzo Ficarra, Alessandro Buttitta, Marta Rossanese, Angela Alibrandi, Giuseppina Anastasi, Alfredo Blandino, Antonio Ieni, Maurizio Martini, Gianluca Giannarini
Publikováno v:
Société Internationale d’Urologie Journal, Vol 5, Iss 2, Pp 122-132 (2024)
Objectives: Few studies have examined the role of prostate MRI in patients with suspicious digital rectal examination (DRE) and/or PSA > 10 ng/mL. In a cohort of non-screened patients with suspicious DRE, we investigated the rate of avoidable prostat
Externí odkaz:
https://doaj.org/article/e2516ba7a72d48c788aaf2a1d7caf03c
Autor:
Valeria Pecci, Fabiola Troisi, Aurora Aiello, Sara De Martino, Angela Carlino, Vincenzo Fiorentino, Cristian Ripoli, Dante Rotili, Francesco Pierconti, Maurizio Martini, Manuela Porru, Francesco Pinto, Antonello Mai, Pier Francesco Bassi, Claudio Grassi, Carlo Gaetano, Alfredo Pontecorvi, Lidia Strigari, Antonella Farsetti, Simona Nanni
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background About 30% of Prostate cancer (PCa) patients progress to metastatic PCa that remains largely incurable. This evidence underlines the need for the development of innovative therapies. In this direction, the potential research focus
Externí odkaz:
https://doaj.org/article/2ef6b3a5976845e2bc6148989f39a138
Autor:
Ludovica Pepe, Vincenzo Fiorentino, Cristina Pizzimenti, Giuseppe Riganati, Mariausilia Franchina, Marina Micali, Fernanda Russotto, Antonio Ieni, Giovanni Tuccari, Guido Fadda, Francesco Pierconti, Maurizio Martini
Publikováno v:
Diseases, Vol 12, Iss 9, p 219 (2024)
Background/Objectives: Bladder cancer is a prevalent urinary system malignancy and urinary cytology is widely used for its screening and follow-up. A novel diagnostic tool called Bladder Epicheck® (BE) is increasingly being used for monitoring the r
Externí odkaz:
https://doaj.org/article/8785e3b87042493dbb4b657f0bd09a85
Autor:
Antonio Ieni, Cristina Pizzimenti, Vincenzo Fiorentino, Mariausilia Franchina, Antonino Germanò, Giovanni Raffa, Maurizio Martini, Guido Fadda, Giovanni Tuccari
Publikováno v:
Analytical Cellular Pathology, Vol 2024 (2024)
Among autophagic-related proteins, p62/SQSTM1/Sequestosome-1 represents a relevant actor in cellular proliferation and neoplastic growth. Although, recently, p62 expression has been analyzed in different neurodegenerative and glial neoplastic disease
Externí odkaz:
https://doaj.org/article/e40b7ba29f474b0797d0e59675c9582b
Autor:
Vincenzo Fiorentino, Pietro Tralongo, Luigi Maria Larocca, Cristina Pizzimenti, Maurizio Martini, Francesco Pierconti
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Treatment of metastatic renal cell carcinoma (mRCC) has radically changed, switching from interferon alfa (IFN-α) and high-dose interleukin−2 (HD IL−2) to new targeted therapies directed against tumoral neoangiogenesis, the mammalian target of t
Externí odkaz:
https://doaj.org/article/220fd9f0bf7148df9112cf602ab4622a
Autor:
Silvia Chiesa, Antonella Mangraviti, Maurizio Martini, Tonia Cenci, Ciro Mazzarella, Simona Gaudino, Serena Bracci, Antonella Martino, Giuseppe M. Della Pepa, Martina Offi, Marco Gessi, Rosellina Russo, Matia Martucci, Francesco Beghella Bartoli, Luigi M. Larocca, Liverana Lauretti, Alessandro Olivi, Roberto Pallini, Mario Balducci, Quintino Giorgio D’Alessandris
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Predictive factors for response to regorafenib in recurrent glioblastoma, IDH-wildtype, are scarcely recognized. The objective of this study was to identify molecular predictive factors for response to regorafenib using a clinically availabl
Externí odkaz:
https://doaj.org/article/01dad8e8326a41d0835857d94c7f6246
Autor:
Giorgia Pedini, Mariachiara Buccarelli, Fabrizio Bianchi, Laura Pacini, Giulia Cencelli, Quintino Giorgio D’Alessandris, Maurizio Martini, Stefano Giannetti, Franceschina Sasso, Valentina Melocchi, Maria Giulia Farace, Tilmann Achsel, Luigi M. Larocca, Lucia Ricci-Vitiani, Roberto Pallini, Claudia Bagni
Publikováno v:
Cell Death and Disease, Vol 13, Iss 8, Pp 1-13 (2022)
Abstract Converging evidence indicates that the Fragile X Messenger Ribonucleoprotein (FMRP), which absent or mutated in Fragile X Syndrome (FXS), plays a role in many types of cancers. However, while FMRP roles in brain development and function have
Externí odkaz:
https://doaj.org/article/5dd121580cbe4c19bab177623695c5f7
Autor:
Riccardo Nocini, Matteo Vianini, Ilaria Girolami, Luca Calabrese, Aldo Scarpa, Maurizio Martini, Patrizia Morbini, Stefano Marletta, Matteo Brunelli, Gabriele Molteni, Anil Parwani, Liron Pantanowitz, Albino Eccher
Publikováno v:
Clinical and Experimental Dental Research, Vol 8, Iss 3, Pp 690-698 (2022)
Abstract Objectives and background: Oral squamous cell carcinoma (OSCC) is a highly malignant disease with an increasing incidence. The need to improve therapeutic strategies for patients affected by OSCC is an urgent challenge. Currently, the advent
Externí odkaz:
https://doaj.org/article/6c6adcc8a12e45dd90a5cb22af64319d